165.64
Iqvia Holdings Inc stock is traded at $165.64, with a volume of 1.45M.
It is down -0.27% in the last 24 hours and up +2.30% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$166.09
Open:
$168.58
24h Volume:
1.45M
Relative Volume:
0.72
Market Cap:
$27.81B
Revenue:
$16.30B
Net Income/Loss:
$1.36B
P/E Ratio:
21.08
EPS:
7.8573
Net Cash Flow:
$2.05B
1W Performance:
-0.83%
1M Performance:
+2.30%
6M Performance:
-6.25%
1Y Performance:
-8.68%
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IQV
Iqvia Holdings Inc
|
165.64 | 27.88B | 16.30B | 1.36B | 2.05B | 7.8573 |
|
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-26 | Upgrade | TD Cowen | Hold → Buy |
| Mar-06-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
IQVIA Holdings Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
IQVIA Holdings Inc. $IQV Stock Position Decreased by Assenagon Asset Management S.A. - MarketBeat
Investor Mood: Is IQVIA Holdings Inc in a long term uptrend2026 Winners & Losers & Weekly Top Performers Watchlists - baoquankhu1.vn
TD Cowen upgrades IQVIA (IQV) to buy and raises price target to $213 - MSN
TD Cowen Upgrades IQVIA (IQV) to Buy and Raises Price Target to $213 - Insider Monkey
Is IQVIA Holdings Inc. (IQV) a buy post earnings? - MSN
Community Trust & Investment Co. Reduces Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. $IQV Shares Acquired by Diversified Trust Co. - MarketBeat
IQVIA Holdings, Inc. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Is Wall Street bullish or bearish on IQVIA Holdings stock? - MSN
Nordea Investment Management AB Sells 1,600,906 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
TD Cowen Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $213 - Moomoo
IQV SEC FilingsIqvia Hldgs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Weakness - Yahoo Finance
Risk Analysis: Is IQVIA Holdings Inc stock influenced by commodity pricesQuarterly Performance Summary & Weekly High Return Opportunities - baoquankhu1.vn
Aug Final Week: What is the target price for IQVIA Holdings Inc stock2026 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
IQVIA Holdings Inc stock faces earnings anticipation amid healthcare analytics boom - AD HOC NEWS
IQVIA Holdings Inc. (IQV) advances clinical research and data capabilities to drive growth - MSN
A Look At IQVIA Holdings (IQV) Valuation After The IQVIA.ai Launch With NVIDIA - Sahm
IQVIA Holdings Inc stock surges in volume on NYSE amid Q4 earnings beat and FY2026 guidance - AD HOC NEWS
IQVIA Holdings Inc stock faces pressure after Q4 earnings beat amid high volume trading on NYSE - AD HOC NEWS
(IQV) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
IQVIA Holdings Inc. $IQV Shares Sold by Lynwood Price Capital Management LP - MarketBeat
IQVIA Leerink Conference: $30 Target Price From AI Data Moat - TIKR.com
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA Holdings Inc. (IQV) offers impressive upside despite AI-linked threats - MSN
CIBC Private Wealth Group LLC Sells 14,961 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
What Makes IQVIA (IQV) a Good Investment? - MSN
Exit Recap: Can IQVIA Holdings Inc lead its sector in growthWeekly Profit Recap & Expert Curated Trade Setups - baoquankhu1.vn
IQVIA - Forbes
Is IQVIA’s New NVIDIA-Powered IQVIA.ai Platform (IQV) Deepening a Durable AI Moat or Raising Complexity? - simplywall.st
Cinctive Capital Management LP Makes New $2.51 Million Investment in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA launches AI platform with NVIDIA technology By Investing.com - Investing.com India
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences - BioSpace
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and De - PharmiWeb.com
IQVIA launches AI platform with NVIDIA technology - Investing.com
FinancialContentIQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences - FinancialContent
IQVIA Holdings Inc. $IQV Shares Sold by Invenomic Capital Management LP - MarketBeat
Farallon Capital Management LLC Decreases Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
Cannell & Spears LLC Sells 28,433 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Earnest Partners LLC Decreases Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Criteria Caixa S.A.U. Takes Position in IQVIA Holdings Inc. $IQV - MarketBeat
Alliancebernstein L.P. Has $683.32 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
Short Interest in IQVIA Holdings Inc. (NYSE:IQV) Drops By 25.5% - MarketBeat
25,369 Shares in IQVIA Holdings Inc. $IQV Purchased by Pinnbrook Capital Management LP - MarketBeat
Integral Health Asset Management LLC Takes $8.55 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. $IQV Shares Sold by Glenmede Investment Management LP - MarketBeat
2Xideas AG Sells 12,419 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Rises 1.1% on Light Trading and Mixed Institutional Activity - Bitget
IQVIA Holdings Hits Day Low of $162.22 Amid Price Pressure - Markets Mojo
Van ECK Associates Corp Sells 9,959 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):